Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

33 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling of Non-small cell lung cancer in Taiwan

ABSTRACT: This study focus on the expression signature between tumor and adjacent normal tissues. Tumor(T) and adjacent normal(N) tissue pairs from 25 stage I lung adenocarcinoma patients were selected for RNA extraction and hybridization on microarrays.

ORGANISM(S): Homo sapiens

SUBMITTER: Yih-Jyh Shann

PROVIDER: E-GEOD-27262 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Publications

Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.

Wei Tong-You W TY Juan Chi-Chang CC Hisa Jiun-Yi JY Su Li-Jen LJ Lee Yuan-Chii G YC Chou Hsiang-Yun HY Chen Jo-Mei M JM Wu Yu-Chung YC Chiu Shao-Chih SC Hsu Chung-Ping CP Liu Kuo-Lin KL Yu Chang-Tze R CT

Cancer science 20120808 9

Increasing evidence suggests that PRMT5, a protein arginine methyltransferase, is involved in tumorigenesis. However, no systematic research has demonstrated the cell-transforming activity of PRMT5. We investigated the involvement of PRMT5 in tumor formation. First, we showed that PRMT5 was associated with many human cancers, through statistical analysis of microarray data in the NCBI GEO database. Overexpression of ectopic PRMT5 per se or its specific shRNA enhanced or reduced cell growth under ...[more]

PMID: 22726390

Similar Datasets

Gene expression profiling of Non-small cell lung cancer in Taiwan

Project description:This study focus on the expression signature between tumor and adjacent normal tissues.

2013-04-10 | GSE27262 | GEO

Tumor-derived Jagged1- and Notch-dependent transcription changes in MC3T3-E1 osteoblasts

Project description:Transcriptional profiling of MC3T3-E1 osteoblasts that were flow cytometry-separated from cocultures with control or Jagged1-overexpressing tumor cells and treated with either DMSO control or 1μM MRK-003 (gamma-secretase inhibitor). One cell line (MC3T3-E1) cells: four different experimental conditions: cultured with (1) control tumor cells + DMSO; (2) Jagged1-overexpressing tumor cells + DMSO; (3) control tumor cells + MRK-003; (4) Jagged1-overexpressing tumor cells + MRK-003. Each experiment has two biological replicates. Total, 8 samples.

2010-08-15 | E-GEOD-20517 | biostudies-arrayexpress

VCAM1 promotes outbreak from dormant bone metastasis

Project description:A weakly bone metastatic variant of the breast cancer cell line MDA-MB-231, SCP6, gave rise to highly bone metastatic sublines (PD1, PD2A-E) after long time dormancy in vivo. These cell lines were subjected to microarray analysis with data drawn from previous studies (Kang et al., 2003; Minn et al. 2005; Lu and Kang 2009; Lu and Kang 2010). Keywords: Cell type comparison 12 cell lines (parental MDA-MB-231 with biological repeats; weakly bone metastasis variants: SCP3, SCP4 and SCP6; post-dormancy sublines of SCP6: PD1, PD2A, PD2B, PD2C, PD2D, PD2E and PD2R) were cultured and subjected to Affymetrix microarray analysis. Data were analysed with Genespring software.

2011-01-30 | E-GEOD-20611 | biostudies-arrayexpress

Differential miRNA expression profiles betweenHBV-related HCC tumor versus non-tumor liver tissue

Project description:miRNA played an important role in the process of carcinogenesis in HBV related hepatocellular carcinoma. Therefore, we performed miRNA microarray to evaluate the miRNAs that expressed differentially between HCC tumor versus non-tumor liver tissues. RNA was extracted from snap fresh tissue collected from resected HCC tumor and adjacent non-tumor liver tissues. All HCC tumors were HBV-associated HCC.

2015-07-22 | E-GEOD-69580 | biostudies-arrayexpress

Healthy, adjacent normal and tumor colon cells

Project description:Healthy, adjacent normal and tumor colon cells

| PRJNA700872 | ENA

LMWF_EC

Project description:ECFCs and HUVECs were washed and placed overnight in EBM-2 + 2% FCS. The next morning, medium was replaced by EBM-2 + 2% FCS + 10 µg/mL LMWF or by EBM-2 + 2% FCS alone. After 6 hours or 24 hours of treatment, cells were washed with PBS, detached with accutase. After washing and centrifugation steps, the pellet was resuspended in RLT buffer (Qiagen, Venlo, Netherlands) containing beta mercaptoethanol (Sigma, St Louis, MO, USA) and stored at -80°C. Total RNA was isolated by using the RNeasy Mini Kit (Qiagen) as recommended by the manufacturer. Total RNA concentration and integrity was assessed by Nanodrop (Thermo Fisher Scientific, Waltham, USA) and by microchip electrophoresis (Agilent technologies, Santa Clara, CA, USA). Total RNA was amplified using a kit from Ambion (Carlsbad, CA, USA) and applied to Human HT-12 expression beadchips (Illumina, San Diego, CA, USA), a genome wide array with 37 804 probes, according to the manufacturer’s instructions. Data were extracted and normalized using GeneSpring GX (Per Chip: Normalize to 50th percentile; Per Gene: Normalize to median). The working lists were created, filtering probes with detection p-values<0.05 for at least half of the arrays. To control for systematic bias, unsupervised hierarchical clustering was performed, showing that samples are segregated according to the treatment groups. Differentially expressed genes with an expression fold change greater than 1.5 fold were selected using the Student test, with a significance p-value<0.05, including Bonferroni and Benjamini Hochberg false discovery detection. Differential expression of the chosen genes was assessed using supervised hierarchical clustering. The interpretation of the resulting gene lists was performed using the Ingenuity® interface. Heatmaps were generated with R. Each dataset was derived from at least four biologically independent replicate samples.

2016-09-25 | E-MTAB-3925 | biostudies-arrayexpress

Alzheimer's Disease Dataset

Project description:FK506 binding protein 51kDa (FKBP51/FKBP5) is part of a mature heat shock protein 90kDa (Hsp90) chaperone complex that preserves tau. Microarray analysis of human brains reveal that FKBP51 gene expression selectively increased with age and Alzheimer's disease, which correlated with demethylation of the regulatory regions in the FKBP5 gene. Moreover, FKBP51 levels significantly correlated with Braak pathological staging. In addition, we show that in brains devoid of FKBP51, tau levels are reduced. Recombinant FKBP51 and Hsp90 synergize to block tau clearance through the proteasome and produce T22-positive tau oligomers. Overexpression of FKBP51 in a tau transgenic mouse model revealed that FKBP51 preserved tau species, including phosphorylated and oligomeric tau that have been linked to Alzheimer's disease pathogenesis. FKBP51 blocked amyloid formation and decreased tangle load in the brain. These alterations in tau turnover and aggregate structure culminated in enhanced neurotoxicity. We propose a model where age-associated increases in FKBP51 levels can out-compete the association of other pro-degradation Hsp90 co-chaperones, resulting in neurotoxic tau accumulation. Thus, strategies aimed at attenuating FKBP51 levels or its interaction with Hsp90 could be therapeutically relevant for Alzheimer's disease and other tauopathies. These AD cases were processed simultaneously with the control cases (young and aged) included in GSE11882 Postmortem brain tissue was collected from ADRC brain banks. Cases were preferentially selected where 3 or more brain regions were available

2014-04-21 | E-GEOD-48350 | biostudies-arrayexpress

MMP3 treatment of Panc-2 cells

Project description:Response of pancreas cancer cells to treatment with recombinant MMP3 Cells were treated with 100U/ml MMP3 for 4 days, then isolated for RNA. The submitted experiments represent two different experiments performed at different times

2014-05-29 | E-GEOD-50931 | biostudies-arrayexpress

Genomic hybridizations for the parents and progeny of the Toxoplasma gondii I X III genetic cross

Project description:The parents and progeny of the I X III genetic cross were genotyped using the ToxoGeneChip in order to generate a more detailed genetic map. We also used the genomic hybridization data to look for copy number variations (CNV) and segmental duplications. The ToxoGeneChip microarray (http://ancillary.toxodb.org/docs/Array-Tutorial.html) was used to hybridize genomic DNA for the parents and progeny of the I X III cross. The parents of the cross are CTGara and GT1-Fudr. The rest comprise the 34 informative progeny.

2012-01-11 | E-GEOD-26607 | biostudies-arrayexpress

Analysis of milk removal frequency on bovine mammary gene expression

Project description:Regulation of milk synthesis and secretion is controlled mostly through local (intra-mammary) mechanisms. To gain insight into the molecular pathways comprising this response, an analysis of mammary gene expression was conducted in 12 lactating cows shifted from twice daily to once daily milking. Tissues were sampled by biopsy from adjacent mammary quarters of these animals during the two milking frequencies, allowing changes in gene expression to be assessed within each animal. Using bovine-specific, oligonucleotide arrays representing 21,495 unique transcripts, a range of differentially expressed genes were found as a result of less frequent milk removal. A total of 12 microarrays were used in this study. Each array was hybridized with RNA derived from a mammary sample taken at each biopsy time point, such that the twice-a-day milked sample and once-a-day milked sample were contained on the same slide for each animal (12 animals). Six of the microarrays represented animals previously shown to demonstrate a âlargeâ reduction in milk yield, whereas the other six arrays represented animals that previously displayed a âsmallâ reduction in milk yield when milked once per day. Half of each yield loss group (three animals) was represented by once-a-day milked/twice-daily-milked samples for Cy5/Cy3 labelling, with the other half labelled with the opposite dye configuration. This meant that six of 12 arrays were 'dye swapped', but with biological replicates as opposed to identical replicates.

2010-05-16 | E-GEOD-16876 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data